The concern of generic rivalry has long loomed over copyright’s famous drug, Viagra, raising questions about the outlook of connected medicinal ventures. While early periods saw impressive profits, the patent lapse has created the way for discounted copies, potentially lowering profitability and presenting a real risk for shareholders looking for